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A B S T R A C T
Background: The purpose was to investigate survival of cartilage repair in the knee joint by osteochondral au-
tograft transfer stratified by location of the lesion; patellofemoral joint (N=26) versus the medial or lateral
femoral condyles (N=58).
Methods: For survival analyses, “failure” was defined as the event of a patient reporting a poor Lysholm score
(below 65 points) or undergoing a knee replacement procedure.
Results: The survival distribution was not significantly different between the patellofemoral joint and the ti-
biofemoral joint groups.
Conclusions: The current study suggest that similar long-term outcome can be expected after OAT procedures for
the patellofemoral or tibiofemoral joint.
Level of evidence: Therapeutic study, Level III.
1. Introduction
Focal chondral lesions of the knee impair quality of life to a similar
degree as in patients scheduled for knee replacement1 and provoke
symptoms and reduced function to a greater degree than that of patients
about to undergo a reconstruction of a torn anterior cruciate ligament.2
Hjelle and co-workers found focal chondral lesions in 19% of 1000
consecutive knee arthroscopies.3 They were localized to the medial
femoral condyle in 58%, patella in 11%, lateral tibia in 11%, lateral
femoral condyle in 9%, trochlea in 6%, and the medial tibia in 5%.
Thus, patellofemoral joint (PF) lesions constituted 17% and medial- or
femoral condyle (FC) 67% of the chondral defects of the knee.3
Chondral lesions do not heal spontaneously and continue to pose a
therapeutic challenge to orthopaedic surgeons.4,5 Thus, since the early
1990s a number of new surgical treatment options have been in-
troduced including osteochondral autograft transfer (OAT) from less
weight-bearing areas of the knee joint to the defect.6–8 The technique
was popularized by Hangody et al. under the name mosaicplasty9,10 as
grafts are placed in a mosaic fashion to cover most of the defect.
Some studies have suggested that localization of the cartilage lesion
might affect outcome after surgery, specifically, that inferior results are
seen in PF lesions. However, a firm conclusion is yet to be established as
results are contractionary, possibly due to great differences in study
design.11–18
We have previously published short-, medium- and long-term out-
come of articular cartilage repair of the knee using the mosaicplasty
technique.19–24 The present work aimed, for the first time, to compare
the long-term survival (by the Kaplan-Meier method) of the cartilage
repair by OAT of PF lesions versus FC lesions. The null-hypothesis was
that the occurrence of failure was not different between the two groups
of different sites.
2. Materials and methods
2.1. Experimental protocol
All patients undergoing a cartilage repair procedure at our institu-
tion from 1998 to 2003 were registered prospectively in a local in-
stitutional database (Access, Microsoft Corporation, Redmond, USA).
The baseline data were acquired from standardized forms completed by
both the patient and the surgeon. The form contained details about
preoperative symptoms and function (including that of the Lysholm
knee score)25 and perioperative findings and details about the surgery
performed, including localization and size of the articular cartilage
defect, similar to the system recommended by the International Carti-
lage Repair Society.26
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We included patients of age 60 years or younger at surgery; with a
symptomatic focal full-thickness articular chondral defect of the pa-
tellofemoral joint (patella or trochlea, PF group) or the medial or lateral
femoral condyles (FC group) verified by arthroscopic examination and
treated with mosaicplasty. Exclusion criteria (at the time of surgery)
were: joint space narrowing on standard anteroposterior radiographs
(to a space < 4mm), more than 5° varus or valgus malalignment,
previous or concurrent realignment surgery, ligament instabilities or
the inability to follow the rehabilitation protocol.
Outcome evaluation was performed by the Lysholm score25,27 and
any report of the patient undergoing a knee replacement surgery of the
same knee (after the index surgery). Data were prospectively collected
at several time-points after the surgery. For the first few years, data
were collected at routine check-ups at the out-patient department,
thereafter by the patients completing and returning standardized
questionnaires sent (by researchers not involved in the treatment) by
mail every 2–3 years, most recently in 2017.
2.2. Surgical techniques
After arthroscopic evaluation, a mosaicplasty procedure was per-
formed. The lesion was debrided with curettes down to subchondral
bone, and around the edges until healthy surrounding cartilage. The
area of the lesion was calculated (after the debridement) as millimetres
squared. The mosaicplasty procedure (Smith and Nephew Inc.,
Andover, MA, USA) was performed as described by Hangody et al.9,10
The grafts were harvested from the periphery of the femoral condyles at
the level of the patellofemoral joint and transplanted to corresponding
burr holes in the defect in a mosaic fashion in the effort to cover as
much as possible of the area of the lesion. Most lesions on the medial
femoral condyle was treated by a medial parapatellar mini-arthrotomy,
used both for harvesting (in knee extension) and transplantation (in
knee flexion) of the grafts. In all patellofemoral joint lesions, a standard
arthrotomy with eversion of the patella was undertaken.
2.3. Rehabilitation
For all patients, continuous passive motion was started within a few
hours after the operation and was continued for the duration of the stay
in hospital (4–7 days). The patients were instructed in use of crutches
by a physiotherapist and maintained foot-touch weight-bearing for 6
weeks. Thereafter, full weight-bearing was gradually introduced.
Physiotherapy was commenced at the hospital and continued after the
discharge. Initial exercises included stretching, straight-leg raise and
passive motion - progressing through active closed kinetic chain ex-
ercises including stationary bicycling to dynamic weight training.28 The
Ethical Committee at our institution reviewed and approved of the
study (HDS ID 1998–0201). All patients gave their informed consent
prior to inclusion in the study.
2.4. Statistical analyses
Statistical analyses were performed with the Statistical Package for
the Social Sciences (SPSS Inc., Chicago, Illinois, USA) on a personal
computer. An a priori P-value less than 0.05 was considered statistically
significant. As measures of central location and spread of data, mean
and standard deviation (SD) or median and range were calculated. A
two-tailed unpaired T-test was used to compare the sets of continuous
data between subgroups of the patient population (at the same time
point). For comparing binominal data of subgroups, the chi-square test
was used.
For survival analyses, “failure” was defined as the patient reporting
a poor Lysholm score below 65 points (from 12 months after the sur-
gery and onwards - when patients had normally finished their re-
habilitation)25 and/or undergoing an ipsilateral knee replacement
procedure.23 Time from the index cartilage surgery until the event of
failure was recorded and used for analyses. The Kaplan-Meier method
was used for construction of a survival functions plot for the event
“failure”. Log Rank (Mantel-Cox) test was used for comparison of sur-
vival distributions in the two groups (PF and FC).29
3. Results
84 patients (35 women and 49 men) with median age 34 years
(Range 16–60) were included in the study. Twenty-six (PF group) pa-
tients were treated by mosaicplasty for an articular cartilage defect of
the patella (N= 19) or trochlea (N=7). Fifty-eight (FC group) were
treated for a lesion on the medial (N=51) or lateral (N= 7) femoral
condyle.
At the time of surgery, the median symptom duration was 48
months (Range 1–360). The median total area of cartilage defect(s)
treated was 300 (Range 100–500) mm2, with the use of median 4 os-
teochondral grafts (Range 1–11). The right knee N=57 (68%) was
more often treated than the left knee N=27 (32%). The two groups did
not differ significantly regarding distribution of gender; mean age at
surgery; mean duration of symptoms at the time of surgery; distribution
of right versus left knee; or the mean treated area (Table 1). The PF
group reported significantly lower baseline Lysholm score (Table 1).
The frequency of knee replacement surgery (KR) and poor outcome/
failure (Lysholm<65 or KR), and mean time to failure were not sig-
nificantly different between the groups (Table 2). The survival dis-
tribution (Fig. 1) was not significantly different between the patello-
femoral joint and the tibiofemoral joint groups, Log Rank (Mantel-Cox)
0.117 (P=0.732).
4. Discussion
The most important finding of the present study was that the sur-
vival distribution was not significantly different between the patello-
femoral joint and the tibiofemoral joint groups (N.s). The results
therefore suggest that similar long-term clinical effectiveness can be
expected after undergoing mosaicplasty of knee articular cartilage le-
sions in the patellofemoral joint and the tibiofemoral joint. For both
sites, most of the OAT repairs remained intact (per definition of the
study) for many years, but eventually gradually failed within the 18-
year follow-up in about 50%, in both groups. Still, we concur that many
patients have had a reasonably good knee function for many years after
the OAT procedure. Further, one may speculate that the development of
symptomatic osteoarthritis has possibly been postponed by the cartilage
repair in (both localizations). To our best knowledge, this is the first
Table 1
Demographic data for patients (N=84) undergoing mosaicplasty of the pa-
tellofemoral joint (PF) or the femoral condyles (FC). Mean (SD).
PF (N=26) FC (N=58) P-value
Male/Female 12/14 37/21 0.13 (n.s.)
Age at surgery 35 (10) 35 (9) 0.91 (n.s.)
Duration of symptoms (months) 68 (57) 82 (80) 0.44 (n.s.)
Right/Left knee 21/5 36/22 0.09 (n.s.)
Treated area (mm2) 290 (124) 298 (123) 0.76 (n.s.)
Baseline Lysholm score (Lys) 41 (17) 49 (14) 0.02a
a Statistically significant difference.
Table 2
Frequency of knee replacement surgery (KR) in same knee, frequency of failure
(Lys< 65 or KR), and mean time (years) to failure. Mean (SD).
PF (N=26) FC (N=58) P-value
Knee replacement (KR). N (%) N=5 (19%) 9 (16%) 0.8 (n.s.)
Poor (Lys< 65 or KR). N (%) 15 (58) 28 (48) 0.5 (n.s.)
Time to failure. 9 (5) 8 (5) 0.3 (n.s.)
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study to compare the long-term survival of the cartilage repair by OAT
of PF lesions versus FC lesions.
The PF group reported a significantly lower baseline Lysholm than
that of the FC group. Low baseline Lysholm score has been identified as
an important predictor for worse outcome in cartilage repair surgery.30
Further, the majority of the FC defects was managed by a short medial
parapatellar incision, whereas a large arthrotomy with luxation of the
patella was warranted for all the PF cases. Both factors (lower baseline
Lysholm and more invasive surgery) would probably represent a worse
prognosis in the PF group. Still, we found no significant difference in
the long-term outcome, enhancing the impression that a PF localization
is in no way a contraindication for performing an OAT procedure.
In the present study, the Lysholm score was used for knee rating
regarding symptoms and function. This decision was made when the
quality database was established more than 20 years ago. Newer, more
modern knee rating scores may have been preferred today. Still, re-
cently reported studies of cartilage surgery using Lysholm score is
prevailing12,18,20–24,28,31 and the score has indeed proven adequate
psychometric performance for outcome assessment of various chondral
disorders of the knee.27 Failure was defined as a poor clinical outcome
(Lysholm score< 65 points)25 or a knee replacement procedure,31
whichever event that took place first.23 Other authors have included
other more minor re-interventions (than a knee replacement) as a
failure.32 However, by including the event of Lysholm score dropping
below 65 points as a failure, any relevant re-intervention would gen-
erally be picked up, as it would be predated (and initiated) by a poor
outcome (even if the new procedure improved the symptoms and pre-
cluded/delayed a knee replacement).
One of the main difficulties in measuring the outcome of long-term
clinical studies on articular cartilage repair is that an increasing per-
centage of the patients are having a knee replacement. As a knee score
is often the main outcome variable, authors tend to exclude the re-
placement cases, acknowledging that the score represents the knee re-
placement and not the original cartilage report. However, by reporting
the average score for only the non-failures, a large bias (towards re-
porting a much too optimistic results) is introduced.31 Further, “failure”
is generally restricted to the occurrence of a knee replacement, dis-
regarding the fact that many patients experience a poor result, without
undergoing a knee replacement. Thus, we have suggested defining
failure as a poor Lysholm score< 65 in addition to undergoing a knee
replacement procedure.21,23
Another important difficulty in long-term clinical studies on ar-
ticular cartilage repair is maintaining an acceptable follow-up rate as
the patients move; get bored answering the questionnaires; get old and
mentally reduced; or die. Using survival analyses solves this issue by
introducing “censored data”, the recording of the latest point of time of
Fig. 1. Kaplan-Meier survival functions plot for the event “failure” (a knee replacement procedure in the same knee or Lysholm score<65) after cartilage repair
surgery (PF solid line; FC dashed line; + censored data).
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survival, in patients with a repair that do not fail during the study
period.23,29,31,32
We observed a gradual accumulation of failures of the OAT cartilage
repair in both groups (of different localization). In contrast to cell-based
techniques such as microfracture (mesenchymal stem cells) and ACI
(chondrocytes), the OAT procedures does not rely on cell multiplication
and differentiation, which may, unfortunately, result in other types of
connective tissue than articular hyaline cartilage.28 Thus, at the end of
the OAT procedure, the former articular cartilage defect has already
been replaced by a mosaic of transplants of normal hyaline cartilage
and subchondral bone.9 Experimental animal studies and human clin-
ical studies have shown that osteochondral grafts maintain their hya-
line cartilage coverage and that the subchondral bony part unites with
the surrounding bone.9,33 However, the long-term results may be
hampered by the donor site morbidity; inadequate bonding between the
cartilage cylinder grafts and towards the normal surrounding cartilage;
and any non-geometric/anatomic reconstruction, including proud or
short/low cylinders and incorrect angle placements.34–37 These factors,
in addition to any other inherit predisposing factor (genetic, physiolo-
gical or mechanical) may explain the tendency to development of os-
teoarthritis (OA) in the long run and deterioration of the clinical out-
come over time.20,22,23
Regarding the influence of the localization of the articular cartilage
defect on the outcome, conclusions from previous reports are somewhat
contradictory. Still, it seems that most studies on this subject conclude
with a poorer outcome after OAT procedure in PF joint lesions com-
pared to that of the FC. However, some of the studies are hampered
with various short-comings (including study design, short follow-up
and small number of included patients), and the scientific evidence, in
our respectful opinion, for the latter conclusion, is weak. Bentley et al.11
compared OAT (N=42) and ACI (N=58) procedure with a mean
follow-up of 19 (Range, 12–26) months. Regarding the OAT group, the
macroscopic ICRS grading of the repair tissue at one year (by routine
arthroscopy) was significantly inferior in the patella cases (N= 5)
compared to lesions located on the femur.11 Hangody et al.12 reported
on the outcome of mosaicplasty procedures (N=831), mostly in the
knee, including 597 FC and 118 PF procedures performed at their in-
stitutions between February 1992 and February 2002. Based on various
knee scores (including the Lysholm score), they found a significantly
higher good-to-excellent outcome rate in the FC group (91%) compared
to the PF group (74%) at 1–10 year of follow-up.12
Ollat et al.14 performed a minimum 5-year retrospect multicentre
follow-up study of 142 patients with cartilage lesions of various loca-
tions. They found that medial condyle defects had significantly better
ICRS clinical and Hughston scores than lateral condyle or PF joint de-
fects (N=11).14 Panics et al.15 followed 61 soccer players who un-
derwent mosaicplasty and performed the final evaluation at an average
of 10 (range, 2–17) years. There were five PF cartilage lesions in their
series (4 patella, 1 trochlea). None of these patients were able to return
to their professional sport after the treatment, whilst 79% of those who
were treated for a FC lesion did.15 Baltzer et al.16 performed a short-to
mid-term (mean 26 months) follow-up study of 112 middle-aged (mean
48 years) patients who had had an OAT procedure of cartilage lesions of
varying location, identifying possible predictors of clinical outcome,
evaluated by WOMAC Index and the Visual Analogue Scale (VAS) for
pain. They found lesion location at the patella to be the only significant
risk factor for a poor result.16
In contrast, some recent studies report satisfactory outcome after
OAT procedure on the patella17 and the PF joint.13,18 Karataglis et al.
followed 36 patients (37 procedures) for mean 37 (Range, 18–73)
months after an OAT procedure that was located to the FC in 26 cases
and PF joint in 11 cases.13 They concluded that no correlation was
found between patient age, the size of the lesion or its localization and
the functional outcome as depicted by the Tegner activity scale and the
Activities of Daily Living Scale of the Knee Outcome Survey.13
Further, Emre et al. reviewed retrospectively 33 patients who
underwent mosaicplasty for PF cartilage defects.18 All patients were
followed for 12–24 months (mean 19 months) using Lysholm knee score
for evaluation of the clinical outcome. The mean Lysholm knee score
increased from 52 points at baseline to 86 at the final follow-up
(P < 0.001). The results were good in 24 cases and fair in 9 cases. No
patients had poor results. Chadli et al. reported on the clinical outcome
at a 16–50 months follow-up (Mean 29 months) on a series of 8 cases of
OCD of the patella in (12-17 year-old) adolescents treated by mosaic-
plasty.17 From baseline to the last follow-up a significant improvement
was observed in the mean Lysholm score from 54 to 89, and mean IKDC
score from 50 to 87. Radiographs and MRI showed a complete in-
tegration of grafts at the latest follow-up with a satisfactory re-
construction of the joint surface.
The strengths of the current study include a rather large population
(N=84); a robust outcome measure, failure, defined as a knee re-
placement or a poor Lysholm score; a high follow-up rate, 100%, by
including both failures and censored data; a long total follow-up time
approaching 20 years; the use of prospective registration of data; and
the inclusion of a patient administered outcome score. The weaknesses
include the lack of a routine second-look arthroscopy; an MRI ex-
amination to evaluate the repair; or a routine radiological evaluation of
the development of osteoarthritis. Also, no non-operatively treated
control-group was included for evaluation of the effectiveness of sur-
gery versus the natural course of knee joint cartilage lesions.
5. Conclusion
The most important finding of the present study was that the sur-
vival distribution was not significantly different between the patello-
femoral joint and the tibiofemoral joint groups. For both sites, most of
the OAT repairs stayed intact for many years, but eventually failed
within 18 years in almost half of the cases. Still, we concur that many
patients have had a reasonably good knee function for many years after
the OAT procedure, independent on the localization (PF or FC).
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